focus -WSS

focus

author：knowledge 2025-10-02 18:05:46 - browse：389

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Monday approved a gene therapy for metachromatic leukodystrophy, a devastating genetic disorder that eats away at affected children’s neurons.

The medicine, marketed as Lenmeldy, is the first treatment for MLD, which is otherwise fatal. Lenmeldy has to be given before symptoms appear or, in some cases, after the first signs of disease, so it won’t be helpful for many patients living with MLD today. But when given in time, it appears to be near-curative, allowing some children to grow up and attend school with unaffected peers.

Lenmeldy is already marketed in Europe, under the name Libmeldy, and has helped a handful of patients in the U.S. who were treated under compassionate use, as their doctors feared they didn’t have time to wait for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： There's no autism epidemic. It's an autism diagnosis epidemic

WSS

Decaf coffee targeted by food safety group under obscure FDA rule

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Oprah kicked off a national conversation on obesity. Let's have it

Study says nonprofit hospitals fall short in charity care spending

Covid vaccine financial winners and losers, from Pfizer to Novavax

knowledge

focus

Wikipedia

Jerome Adams on the need for new antivirals for Covid

Primary care physicians play key roles in Alzheimer's management

Virginia high school admissions case could be legal follow

Readout LOUD podcast: mifepristone case, GLP

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: Merck, Vertex, and Viking updates

Activists slam private health insurers over coverage restrictions

The unintended consequences of overturning Roe v. Wade

How one medical school became remarkably diverse

Assistant physicians can help address the primary care shortage

leisure time

Transgender sports debate: Physicians say bans are health issue

FDA panel to weigh safety of artificial wombs for preterm births

Oprah kicked off a national conversation on obesity. Let's have it

Why the drug industry's warnings on the IRA's impact fall short

Free Covid tests will again be offered to all U.S. households

Midwives could help bridge maternal health disparities in the U.S.

knowledge

hotspot

focus

explore